Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 465175, 6 pages
http://dx.doi.org/10.1155/2014/465175
Clinical Study

Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients

Department of Radiation Oncology, “La Sapienza” University, Sant’Andrea Hospital of Rome, Via di Grottarossa 1035-1039, 00189 Rome, Italy

Received 7 February 2014; Accepted 14 March 2014; Published 23 April 2014

Academic Editor: Giovanni Luca Gravina

Copyright © 2014 Maurizio Valeriani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Loblaw and P. Cheung, “External beam irradiation for localized prostate cancer—the promise of hypofractionation,” The Canadian Journal of Urology, vol. 13, supplement 1, pp. 62–66, 2006. View at Google Scholar · View at Scopus
  2. M. Ritter, “Rationale, conduct, and outcome using hypofractio-nated radiotherapy in prostate cancer,” Seminars in Radiation Oncology, vol. 18, no. 4, pp. 249–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Cox, J. Stetz, and T. F. Pajak, “Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC),” International Journal of Radiation Oncology * Biology * Physics, vol. 31, no. 5, pp. 1341–1346, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Roach 3rd, G. Hanks, H. Thames Jr. et al., “Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer. Recommendations of the RTOG-ASTRO Phoenix consensus conference,” International Journal of Radiation Oncology * Biology * Physics, vol. 65, pp. 965–974, 2006. View at Publisher · View at Google Scholar
  5. H. Lukka, C. Hayter, J. A. Julian et al., “Randomized trial comparing two fractionation schedules for patients with localized prostate cancer,” Journal of Clinical Oncology, vol. 23, no. 25, pp. 6132–6138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. E. Yeoh, R. H. Holloway, R. J. Fraser et al., “Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial,” International Journal of Radiation Oncology * Biology * Physics, vol. 66, no. 4, pp. 1072–1083, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Zietman, K. Bae, J. D. Slater et al., “Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1106–1111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Kuban, S. L. Tucker, L. Dong et al., “Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer,” International Journal of Radiation Oncology * Biology * Physics, vol. 70, pp. 67–74, 2008. View at Publisher · View at Google Scholar
  9. A. Pollack, G. Walker, E. M. Horwitz et al., “Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer,” Journal of Clinical Oncology, vol. 31, pp. 3860–3868, 2013. View at Publisher · View at Google Scholar
  10. J. M. Martin, T. Rosewall, A. Bayley et al., “Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma,” International Journal of Radiation Oncology * Biology * Physics, vol. 69, no. 4, pp. 1084–1089, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Patel, S. Faria, F. Cury et al., “Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes,” International Journal of Radiation Oncology * Biology * Physics, vol. 86, pp. 534–539, 2013. View at Publisher · View at Google Scholar
  12. G. Soete, S. Arcangeli, G. De Meerleer et al., “Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity,” Radiotherapy and Oncology, vol. 80, no. 1, pp. 78–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Pollack, A. L. Hanlon, E. M. Horwitz et al., “Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial,” International Journal of Radiation Oncology * Biology * Physics, vol. 64, no. 2, pp. 518–526, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. P. A. Kupelian, T. R. Willoughby, C. A. Reddy, E. A. Klein, and A. Mahadevan, “Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per raction) for localized prostate cancer: Cleveland Clinic experience,” International Journal of Radiation Oncology * Biology * Physics, vol. 68, no. 5, pp. 1424–1430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Coote, J. P. Wylie, R. A. Cowan, J. P. Logue, R. Swindell, and J. E. Livsey, “Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicity,” International Journal of Radiation Oncology * Biology * Physics, vol. 74, no. 4, pp. 1121–1127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Leborgne and J. Fowler, “Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison,” International Journal of Radiation Oncology * Biology * Physics, vol. 74, no. 5, pp. 1441–1446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Rene, S. Faria, F. Cury et al., “Hypofractionated radiotherapy for favorable risk prostate cancer,” International Journal of Radiation Oncology * Biology * Physics, vol. 77, no. 3, pp. 805–810, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Dearnaley, I. Syndikus, G. Sumo et al., “Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial,” The Lancet Oncology, vol. 13, no. 1, pp. 43–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Y. Song, B. Schaly, G. Bauman, J. J. Battista, and J. Van Dyk, “Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis,” International Journal of Radiation Oncology * Biology * Physics, vol. 64, no. 1, pp. 289–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Zelefsky, M. Kollmeier, B. Cox et al., “Improved clinical outcomes with highdose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer,” International Journal of Radiation Oncology * Biology * Physics, vol. 84, no. 1, pp. 125–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. N. G. Zaorsky, M. T. Studenski, A. P. Dicker, L. Gomella, and R. B. Den, “Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?” Cancer Treatment Reviews, vol. 39, no. 3, pp. 212–218, 2013. View at Publisher · View at Google Scholar
  22. M. R. Button and J. N. Staffurth, “Clinical application of image-guided radiotherapy in bladder and prostate cancer,” Clinical Oncology, vol. 22, no. 8, pp. 698–706, 2010. View at Publisher · View at Google Scholar · View at Scopus